Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
WMS-1 by WellMarker Bio for Non-Small Cell Lung Cancer: Likelihood of Approval
WMS-1 is under clinical development by WellMarker Bio and currently in Phase I for Non-Small Cell Lung Cancer. According to...
WMS-1 by WellMarker Bio for Bile Duct Cancer (Cholangiocarcinoma): Likelihood of Approval
WMS-1 is under clinical development by WellMarker Bio and currently in Phase I for Bile Duct Cancer (Cholangiocarcinoma). According to...
WMS-1 by WellMarker Bio for Pancreatic Cancer: Likelihood of Approval
WMS-1 is under clinical development by WellMarker Bio and currently in Phase I for Pancreatic Cancer. According to GlobalData, Phase...
WMS-1 by WellMarker Bio for Head And Neck Cancer: Likelihood of Approval
WMS-1 is under clinical development by WellMarker Bio and currently in Phase I for Head And Neck Cancer. According to...
WMS-1 by WellMarker Bio for Colon Cancer: Likelihood of Approval
WMS-1 is under clinical development by WellMarker Bio and currently in Phase I for Colon Cancer. According to GlobalData, Phase...